Gday ahjay ,I was hoping sooner rather than later regarding INSIGHT data,this year not next ,from what the latest annual report stated,
“In July 2017, IKF re- ceived the necessary approvals to commence the INSIGHT trial and has been recruiting patients. We expect IKF will report interim data from the trial in calendar year 2018.
IMM Price at posting:
4.4¢ Sentiment: Buy Disclosure: Held